Fluorescence Angiography for Perfusion Assessment

Type: diagnostic

Status: FDA Approved

Developer: Various medical device companies (e.g., Stryker, KARL STORZ)

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026